Nonuse of oral anticoagulation and outcomes across the ejection-fraction spectrum in acute heart failure with atrial fibrillation

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

About the speaker

Doctor Jumpei Yamamoto

Toho University Ohashi Medical Center, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail

Current clinical use of edoxaban 15 mg in hospitalized patients with heart failure: analysis from the JROAD-DPC database

Doctor Y. Fujimoto (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Anticoagulants and pulmonary embolism: the surprising impact of apixaban on bilateral embolism

Doctor R. Brandao (Amadora, PT)

Presentation thumbnail

Pulmonary Embolism in anticoagulated patients: a retrospective single-centered cohort comparing data from the PIOPED II study

Doctor R. Brandao (Amadora, PT)

Presentation thumbnail

Long-term clinical outcomes of vasodilating beta-blockers in acute myocardial infarction patients with preserved left ventricular ejection fraction after a successful stent implantation

Mr D. Lee (Jeju, KR)

Presentation thumbnail

Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Access the full session

Session thumbnail

ePosters in pharmacology and pharmacotherapy (1)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources